Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The dysplastic nevus: recognition and management.

R L Barnhill1, S Hurwitz, P H Duray

  • 1Department of Dermatology, Yale University School of Medicine, New Haven, Conn.

Plastic and Reconstructive Surgery
|February 1, 1988
PubMed
Summary

Dysplastic nevi may indicate increased melanoma risk, especially with a family history. Most dysplastic nevi do not progress to melanoma, but regular skin checks are crucial for early detection.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The pink papules and plaques of Spitz.

The British journal of dermatology·2019
Same author

Skin biopsy utilization and melanoma incidence among Medicare beneficiaries.

The British journal of dermatology·2016
Same author

Experimental studies with Etheron sponge. Effect of implantation in tumor-bearing animals.

Problemy sovremennoi neirokhirurgii·2014
Same author

Dermabrasion debridement of the deep dermal burn.

Plastic and reconstructive surgery·2010
Same author

C16 laminin peptide increases angiotropic extravascular migration of human melanoma cells in a shell-less chick chorioallantoic membrane assay.

The British journal of dermatology·2007
Same author

Claudin-1 overexpression in melanoma is regulated by PKC and contributes to melanoma cell motility.

Oncogene·2006

Area of Science:

  • Dermatology
  • Oncology
  • Pathology

Background:

  • Atypical or dysplastic nevomelanocytic nevi are controversial lesions.
  • Identifying individuals at increased risk for cutaneous malignant melanoma is crucial.

Purpose of the Study:

  • To review the clinical and histologic criteria for diagnosing dysplastic nevi.
  • To discuss the significance of dysplastic nevi in relation to melanoma risk.
  • To outline management strategies for individuals with dysplastic nevi.

Main Methods:

  • Review of existing literature on dysplastic nevi and their association with melanoma.
  • Analysis of clinical and histopathologic diagnostic criteria.
  • Evaluation of risk factors and progression rates.

Related Experiment Videos

Main Results:

  • Dysplastic nevi exhibit specific clinical (asymmetry, size >5mm, irregular borders, variegated color) and histopathologic features (abnormal melanocyte proliferation, atypia, host response).
  • Individuals with dysplastic nevi and a strong family history of melanoma have a significantly elevated relative risk (148x).
  • The majority of dysplastic nevi are stable or may regress; progression to melanoma is not the norm.

Conclusions:

  • Histopathologic confirmation is essential for diagnosing dysplastic nevi.
  • While dysplastic nevi can indicate increased melanoma risk, especially with family history, most do not progress.
  • Management involves regular skin surveillance, patient self-examination, and sun protection measures.